Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
TORONTO, ONTARIO--(Marketwire - July 6, 2011) - Arch Biopartners Inc ("Arch" or the "Company")(CNSX:ACH)(OTC:FOIFF) today announced that the University of Calgary has extended the...
-
TORONTO, ONTARIO--(Marketwire - June 27, 2011) - Arch Biopartners Inc ("Arch" or the "Company") (CNSX:ACH)(OTC:FOIFF) and its subsidiary Arch Cancer Therapeutics ("ACT") today announced ACT has...
-
TORONTO, ONTARIO--(Marketwire - June 23, 2011) - Arch Biopartners Inc. ("Arch" or the "Company") (CNSX:ACH)(OTC:FOIFF) and its subsidiary Arch Cancer Therapeutics ("ACT") today announced Arch...
-
TORONTO, ONTARIO--(Marketwire - May 24, 2011) - Arch Biopartners Inc ("Arch" or the "Company") (CNSX:ACH)(OTC:FOIFF) and its subsidiary Arch Biophysics Ltd today announced that Arch scientists Randall...
-
TORONTO, ONTARIO--(Marketwire - May 10, 2011) - Arch Biopartners Inc ("Arch" or the "Company") (CNSX:ACH)(OTC:FOIFF) and its subsidiary Arch Biophysics Ltd today announced that Arch scientists have...
-
TORONTO, ONTARIO--(Marketwire - April 15, 2011) - Arch Biopartners Inc ("Arch" or the "Company") (CNSX:ACH)(OTC:FOIFF) today announced it has granted 250,000 stock options with an exercise price of...
-
TORONTO, ONTARIO--(Marketwire - April 11, 2011) - Arch Biopartners Inc ("Arch" or the "Company")(CNSX:ACH)(OTC:FOIFF) and its subsidiary Arch Cancer Therapeutics ("ACT") today announced Arch...